Skip to main content

Lauren Mateja, Managing Editor

Lauren Mateja, Managing Editor
A National Rosacea Society expert roundtable discussed the need to address persistent facial erythema in patients with rosacea through research and management options.
Lauren Mateja, Managing Editor
Though many in-person meetings have put a pause on education in 2020, the Interdisciplinary Autoimmune Summit is forging the way with a new virtual format from July 10 to 12.
Lauren Mateja, Managing Editor
Coronavirus disease, or COVID-19, may still be novel to the dermatology community, but research since its initial appearance in humans have elucidated some of the mystery around the virology and epidemiology of SARS-CoV-2.
Lauren Mateja, Managing Editor
The Centers for Disease Control and Prevention and World Health Organization advise that hand washing is critical to slowing the spread of infection, but patients with dermatitis may need further guidance from their dermatologists.
Lauren Mateja, Managing Editor
Patients with psoriasis and psoriatic arthritis have increased calls to their dermatologist for advice on continuance of their therapy during uncertain times. Guidance from national organizations provide answers that dermatologists can pass on to their patients.
Lauren Mateja, Managing Editor
The number of therapeutic options for rosacea management has expanded, but these treatments can only help patients who have been diagnosed. Rosacea Awareness Month seeks to help identify patients who may otherwise ignore their warning signs.
Lauren Mateja, Managing Editor
As the next generation of students and residents begin their careers in dermatology, multimedia is helping deliver education in new engaging formats, from social networks to videos and podcasts.
Lauren Mateja, Managing Editor
New and emerging therapies such as biologics continue to improve quality of life and outcomes for patients with psoriasis. Biologics that block IL-23 functions present a unique opportunity to provide long-term, effective treatment.
Lauren Mateja, Managing Editor
A murine model showed success in treating atopic dermatitis by activating natural killer cells instead of suppressing the immune response. The Dermatologist spoke with researcher Brian S. Kim, MD, about the future of this immunotherapeutic strategy.
Lauren Mateja, Managing Editor
Across various fields of medicine, telehealth has shown success with patient access and satisfaction. A new clinical trial, which partners a research firm and a major academic center, seeks to demonstrate equivalent outcomes between teledermatology and traditional in-person care.
Back to Top